Global Induced Pluripotent Stem Cells (iPSCs) Market 2022-2028
The global induced pluripotent stem cells market size is projected to grow by USD 2 billion from 2022 to 2028, registering a CAGR of 8.6 percent, according to a new report by Gen Consulting Company.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global induced pluripotent stem cells market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the induced pluripotent stem cells industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the function, reprogramming method, method, application, and region. The global market for induced pluripotent stem cells can be segmented by function: cell analysis, cell culture, cell differentiation, cellular and molecular bioengineering, cellular reprogramming. In 2021, the cell differentiation segment made up the largest share of revenue generated by the induced pluripotent stem cells market. Induced pluripotent stem cells market is further segmented by reprogramming method: integrated, non-integrated. The non-integrated segment was the largest contributor to the global induced pluripotent stem cells market in 2021. Based on method, the induced pluripotent stem cells market is segmented into: DNA-based, protein-based, RNA-based, small molecule-based. The DNA-based segment is estimated to account for the largest share of the global induced pluripotent stem cells market. On the basis of application, the induced pluripotent stem cells market also can be divided into: academic research, drug development, regenerative medicine. The drug development segment held the largest share of the global induced pluripotent stem cells market in 2021 and is anticipated to hold its share during the forecast period. Induced pluripotent stem cells market by region is categorized into: Asia Pacific, Europe, USA, Rest of the World (RoW).
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook